News & Analysis on Clinical Trial Services & Contract Research And Development
A survey has found that difficulties in swallowing pills is widespread among adults, but is rarely discussed with doctors and can prevent some people from taking their medicine. The findings suggest that pharmaceutical companies should devote more...
Diversa has forged a new alliance for the discovery of bioacatalysts used for the manufacture of pharmaceutical intermediates and active ingredients.
A recent trend in drug development has been the re-invigoration of older pharmaceuticals by developing new versions based on just one of the two optical isomers of the active compound, a process known as racemic switching. But critics suggest that...
Applied Biosystems has launched a new product, based on the combination of a new set of reagents with a software package, that promises to speed up genotyping studies carried out on the firm's 3730 and 3730xl analysers, first introduced in 2002.
MorphoSys has entered into a cross-licensing deal with fellow German company Bayer Healthcare for technologies used in the development and production of antibody-based drugs.
Switzerland's Roche is setting up an R&D centre in Shanghai in a move which reflects the growing importance of the country as both a market for pharmaceutical products and a site for drug research.
Affymetrix and liquid-handling specialist Caliper Technologies - now renamed Caliper Life Sciences - are collaborating on ways of automating genomics research carried out using microarrays.